Treatment of Group B Streptococcus UTI with Penicillin
For a symptomatic Group B Streptococcus urinary tract infection in a non-pregnant adult, use penicillin G 12-24 million units IV daily divided every 4-6 hours for 7-14 days, or alternatively ampicillin 2g IV every 4-6 hours.
Rationale and Evidence Base
The provided guidelines focus predominantly on intrapartum prophylaxis and perinatal GBS disease prevention rather than treatment of established UTIs in non-pregnant adults 1, 2, 1, 2, 1. However, the FDA labeling for penicillin G provides dosing guidance for serious streptococcal infections that can be extrapolated to GBS UTI 3.
Dosing Strategy
For serious streptococcal infections (including GBS), the FDA-approved dosing is:
- 12-24 million units/day IV divided every 4-6 hours depending on infection severity 3
- Penicillin G remains the preferred agent due to its narrow spectrum of activity 2
Duration Considerations
While specific duration data for GBS UTI is limited, research evidence suggests:
- Lower tract infection (cystitis): 7 days is reasonable based on general UTI principles 4, 5
- Upper tract infection (pyelonephritis): 14 days may be warranted given GBS pathogenicity 6, 7
Research demonstrates that GBS accounts for approximately 2% of UTIs in non-pregnant adults, with 60% having underlying urinary tract abnormalities 7. The clinical presentation splits equally between upper and lower tract manifestations (37% vs 38%), with poor outcomes in 18% despite treatment 7.
Alternative Regimens
If IV therapy is not feasible or for step-down therapy:
- Ampicillin 2g IV every 4-6 hours is an acceptable alternative 1
- Oral penicillin G has demonstrated urinary excretion levels of 597 mcg/mL in the first 2 hours after 500mg dosing, with 13.4% excreted over 24 hours 8
For penicillin-allergic patients:
- Non-severe allergy: Cefazolin 2g IV initial dose, then 1g IV every 8 hours 1
- Severe allergy (anaphylaxis history): Vancomycin 1g IV every 12 hours 1
Critical Clinical Considerations
When to Consider Combination Therapy
Add gentamicin if clinical response is poor after 48-72 hours. One case report documented penicillin-tolerant GBS (MIC 0.06 IU/mL, MBC 10 IU/mL) causing pyelonephritis and septic arthritis that failed to improve after two weeks of penicillin monotherapy 6. Addition of gentamicin demonstrated synergy (MBC reduced to 0.07 IU/mL with 2.5 mcg/mL gentamicin) and led to clinical improvement 6.
Resistance Patterns
Recent data shows concerning multidrug resistance in GBS UTI isolates:
- 33.6% of isolates are multidrug-resistant 9
- High resistance rates to: tetracycline (81.5%), azithromycin (44.5%), erythromycin (36.3%), clindamycin (26%) 9
- However, no resistance detected to penicillin, ampicillin, or vancomycin 7, 9
- One regional study reported 18.3% penicillin resistance, though this is geographically specific 10
Workup Requirements
Screen for underlying urinary tract abnormalities in all patients with GBS UTI, as 60% have structural or functional genitourinary problems 7. This is particularly important given the association with chronic renal failure (27% of cases) 7.
Common Pitfalls
- Underdosing: Using prophylactic doses (5 million units initial, then 2.5-3 million units every 4 hours) instead of therapeutic doses for established infection
- Inadequate duration: Treating for only 3-5 days as with uncomplicated E. coli cystitis—GBS requires longer courses
- Assuming susceptibility: While resistance is rare, consider bactericidal testing (MBC) if clinical response is poor 6
- Missing underlying pathology: Failure to investigate for urinary tract abnormalities that predispose to GBS colonization
Monitoring
Continue antibiotics for at least 48-72 hours after the patient becomes asymptomatic 3. If symptoms persist beyond 48 hours of appropriate therapy, obtain repeat cultures and consider: